Lonza buying capsule maker for US$5.5b
Zurich
LONZA Group AG, which has a secondary listing in Singapore, has agreed to buy US capsule maker Capsugel SA from KKR & Co for US$5.5 billion, as the Swiss biotech and specialty chemicals company seeks to focus more on health care.
The price includes refinancing of existing Capsugel debt of about US$2 billion, Basel-based Lonza and Capsugel, which has headquarters in Morristown, New Jersey, said in a statement on Thursday.
It added that the deal will be financed by a combination of debt and equity raising of as much as 3.3 billion francs (S$4…
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
OUE Reit obtains S$600 million unsecured sustainability-linked loan
US: Wall St opens higher as more earnings roll in
GE Aerospace raises earnings goal on strong engine sales
BRC Asia to buy 19.9% of steel reinforcement company for S$16 million
Lockheed Martin reports higher sales on strong defence demand
UOI reports 67% surge in Q1 profit before tax to S$8 million, driven by favourable market conditions